Skip to main content
Erschienen in: Obesity Surgery 4/2017

23.09.2016 | Original Contributions

Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study

verfasst von: B. Coffin, V. Maunoury, F. Pattou, X. Hébuterne, S. Schneider, M. Coupaye, S. Ledoux, F. Iglicki, F. Mion, M. Robert, E. Disse, J. Escourrou, G. Tuyeras, Y. Le Roux, C. Arvieux, P. Pouderoux, N. Huten, T. Alfaiate, D. Hajage, S. Msika

Erschienen in: Obesity Surgery | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Super obese patients are recommended to lose weight before bariatric surgery. The effect of intragastric balloon (IGB)-induced weight loss before laparoscopic gastric bypass (LGBP) has not been reported. The aim of this prospective randomized multicenter study was to compare the impact of preoperative 6-month IGB with standard medical care (SMC) in LGBP patients.

Methods

Patients with BMI >45 kg/m2 selected for LGBP were included and randomized to receive either SMC or IGB. After 6 months (M6), the IGB was removed and LGBP was performed in both groups. Postoperative follow-up period was 6 months (M12). The primary endpoint was the proportion of patients requiring ICU stay >24 h; secondary criteria were weight changes, operative time, hospitalization stay, and perioperative complications.

Results

Only 115 patients were included (BMI 54.3 ± 8.7 kg/m2), of which 55 underwent IGB insertion. The proportion of patients who stayed in ICU >24 h was similar in both groups (P = 0.87). At M6, weight loss was significantly greater in the IGB group than in the SMC group (P < 0.0001). Three severe complications occurred during IGB removal. Mean operative time for LGBP was similar in both groups (P = 0.49). Five patients had 1 or more surgical complications, all in the IGB group (P = 0.02). Both groups had similar hospitalization stay (P = 0.59) and weight loss at M12 (P = 0.31).

Conclusion

IGB insertion before LGBP induced weight loss but did not improve the perioperative outcomes or affect postoperative weight loss.
Literatur
1.
Zurück zum Zitat Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641. Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.
2.
Zurück zum Zitat Anandam A, Akinnusi M, Kufel T, et al. Effects of dietary weight loss on obstructive sleep apnea: a meta-analysis. Sleep Breath. 2013;17:227–34.CrossRefPubMed Anandam A, Akinnusi M, Kufel T, et al. Effects of dietary weight loss on obstructive sleep apnea: a meta-analysis. Sleep Breath. 2013;17:227–34.CrossRefPubMed
3.
Zurück zum Zitat Ballantyne GH, Svahn J, Capella RF, et al. Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome. Obes Surg. 2004;14:1042–50.CrossRefPubMed Ballantyne GH, Svahn J, Capella RF, et al. Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome. Obes Surg. 2004;14:1042–50.CrossRefPubMed
4.
Zurück zum Zitat Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:304–11.PubMed Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:304–11.PubMed
5.
Zurück zum Zitat Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21:345–50.CrossRefPubMed Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21:345–50.CrossRefPubMed
6.
Zurück zum Zitat Schwartz ML, Drew RL, Chazin-Caldie M. Laparoscopic Roux-en-Y Gastric bypass: preoperative determinants of prolonged operative times, conversion to open gastric bypasses, and postoperative complications. Obes Surg. 2003;13:734–8.CrossRefPubMed Schwartz ML, Drew RL, Chazin-Caldie M. Laparoscopic Roux-en-Y Gastric bypass: preoperative determinants of prolonged operative times, conversion to open gastric bypasses, and postoperative complications. Obes Surg. 2003;13:734–8.CrossRefPubMed
7.
Zurück zum Zitat Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRefPubMed Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRefPubMed
8.
Zurück zum Zitat Livhits M, Mercado C, Yermilov I, et al. Does weight loss immediately before bariatric surgery improve outcomes: a systematic review. Surg Obes Relat Dis. 2009;5:713–21.CrossRefPubMed Livhits M, Mercado C, Yermilov I, et al. Does weight loss immediately before bariatric surgery improve outcomes: a systematic review. Surg Obes Relat Dis. 2009;5:713–21.CrossRefPubMed
9.
Zurück zum Zitat Ochner CN, Dambkowski CL, Yeomans BL, et al. Pre-bariatric surgery weight loss requirements and the effect of preoperative weight loss on postoperative outcome. Int J Obes. 2012;36:1380–7.CrossRef Ochner CN, Dambkowski CL, Yeomans BL, et al. Pre-bariatric surgery weight loss requirements and the effect of preoperative weight loss on postoperative outcome. Int J Obes. 2012;36:1380–7.CrossRef
10.
Zurück zum Zitat Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3:141–5.CrossRefPubMed Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3:141–5.CrossRefPubMed
11.
Zurück zum Zitat Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg. 2011;146:1300–5.CrossRefPubMed Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg. 2011;146:1300–5.CrossRefPubMed
12.
Zurück zum Zitat Genco A, Lopez-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23:515–21.CrossRefPubMed Genco A, Lopez-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23:515–21.CrossRefPubMed
13.
Zurück zum Zitat Mafort TT, Madeira E, Madeira M, et al. Six-month intragastric balloon treatment for obesity improves lung function, body composition, and metabolic syndrome. Obes Surg. 2014;24:232–40.CrossRefPubMed Mafort TT, Madeira E, Madeira M, et al. Six-month intragastric balloon treatment for obesity improves lung function, body composition, and metabolic syndrome. Obes Surg. 2014;24:232–40.CrossRefPubMed
14.
Zurück zum Zitat van Wissen J, Bakker N, Doodeman HJ et al. Preoperative methods to reduce liver volume in bariatric surgery: a systematic review. Obes Surg 2015. van Wissen J, Bakker N, Doodeman HJ et al. Preoperative methods to reduce liver volume in bariatric surgery: a systematic review. Obes Surg 2015.
15.
Zurück zum Zitat Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.CrossRefPubMed Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.CrossRefPubMed
16.
Zurück zum Zitat Farina MG, Baratta R, Nigro A, et al. Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. Obes Surg. 2012;22:565–71.CrossRefPubMed Farina MG, Baratta R, Nigro A, et al. Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. Obes Surg. 2012;22:565–71.CrossRefPubMed
17.
Zurück zum Zitat Fuller NR, Pearson S, Lau NS, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity (Silver Spring). 2013;21:1561–70.CrossRef Fuller NR, Pearson S, Lau NS, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity (Silver Spring). 2013;21:1561–70.CrossRef
18.
Zurück zum Zitat Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129–33.CrossRef Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129–33.CrossRef
19.
Zurück zum Zitat Giardiello C, Borrelli A, Silvestri E, et al. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obes Surg. 2012;22:1916–9.CrossRefPubMed Giardiello C, Borrelli A, Silvestri E, et al. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obes Surg. 2012;22:1916–9.CrossRefPubMed
20.
Zurück zum Zitat Majanovic SK, Ruzic A, Bulian AP, et al. Comparative study of intragastric balloon and cognitive-behavioral approach for non-morbid obesity. Hepato-Gastroenterology. 2014;61:937–41.PubMed Majanovic SK, Ruzic A, Bulian AP, et al. Comparative study of intragastric balloon and cognitive-behavioral approach for non-morbid obesity. Hepato-Gastroenterology. 2014;61:937–41.PubMed
21.
Zurück zum Zitat Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.CrossRefPubMed Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.CrossRefPubMed
22.
Zurück zum Zitat Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–53.CrossRefPubMed Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–53.CrossRefPubMed
23.
Zurück zum Zitat Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004;14:671–6.CrossRefPubMed Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004;14:671–6.CrossRefPubMed
24.
Zurück zum Zitat Helling TS, Willoughby TL, Maxfield DM, et al. Determinants of the need for intensive care and prolonged mechanical ventilation in patients undergoing bariatric surgery. Obes Surg. 2004;14:1036–41.CrossRefPubMed Helling TS, Willoughby TL, Maxfield DM, et al. Determinants of the need for intensive care and prolonged mechanical ventilation in patients undergoing bariatric surgery. Obes Surg. 2004;14:1036–41.CrossRefPubMed
25.
Zurück zum Zitat Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: the Italian experience with 2, 515 patients. Obes Surg. 2005;15:1161–4.CrossRefPubMed Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: the Italian experience with 2, 515 patients. Obes Surg. 2005;15:1161–4.CrossRefPubMed
26.
Zurück zum Zitat Sullivan S, Kumar N, Edmundowicz SA et al. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc 2015. Sullivan S, Kumar N, Edmundowicz SA et al. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc 2015.
27.
Zurück zum Zitat Layec S, Val-Laillet D, Heresbach D, et al. Gastric tone, volume and emptying after implantation of an intragastric balloon for weight control. Neurogastroenterol Motil. 2010;22:1016.CrossRefPubMed Layec S, Val-Laillet D, Heresbach D, et al. Gastric tone, volume and emptying after implantation of an intragastric balloon for weight control. Neurogastroenterol Motil. 2010;22:1016.CrossRefPubMed
28.
Zurück zum Zitat Bonazzi P, Petrelli MD, Lorenzini I, et al. Gastric emptying and intragastric balloon in obese patients. Eur Rev Med Pharmacol Sci. 2005;9:15–21.PubMed Bonazzi P, Petrelli MD, Lorenzini I, et al. Gastric emptying and intragastric balloon in obese patients. Eur Rev Med Pharmacol Sci. 2005;9:15–21.PubMed
29.
Zurück zum Zitat Mion F, Napoleon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15:510–6.CrossRefPubMed Mion F, Napoleon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg. 2005;15:510–6.CrossRefPubMed
30.
Zurück zum Zitat Goederen-van der Meij S, Pierik RG, Oudkerk PM, et al. Six months of balloon treatment does not predict the success of gastric banding. Obes Surg. 2007;17:88–94.CrossRefPubMedPubMedCentral Goederen-van der Meij S, Pierik RG, Oudkerk PM, et al. Six months of balloon treatment does not predict the success of gastric banding. Obes Surg. 2007;17:88–94.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Genco A, Lorenzo M, Baglio G, et al. Does the intragastric balloon have a predictive role in subsequent LAP-BAND(®) surgery? Italian multicenter study results at 5-year follow-up. Surg Obes Relat Dis. 2014;10:474–8.CrossRefPubMed Genco A, Lorenzo M, Baglio G, et al. Does the intragastric balloon have a predictive role in subsequent LAP-BAND(®) surgery? Italian multicenter study results at 5-year follow-up. Surg Obes Relat Dis. 2014;10:474–8.CrossRefPubMed
Metadaten
Titel
Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study
verfasst von
B. Coffin
V. Maunoury
F. Pattou
X. Hébuterne
S. Schneider
M. Coupaye
S. Ledoux
F. Iglicki
F. Mion
M. Robert
E. Disse
J. Escourrou
G. Tuyeras
Y. Le Roux
C. Arvieux
P. Pouderoux
N. Huten
T. Alfaiate
D. Hajage
S. Msika
Publikationsdatum
23.09.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 4/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2383-x

Weitere Artikel der Ausgabe 4/2017

Obesity Surgery 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.